Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000)
Clicks: 236
ID: 115565
2002
With reports of increasing resistance to antimicrobial agents among Pseudomonas aeruginosa clinical isolates worldwide, the activities of cefepime and eight other broad-spectrum beta-lactams against 6969 isolates collected during 1997-2000 from the four regions of the SENTRY Antimicrobial Surveillan …
Reference Key |
rn2002diagnosticgeographic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Jones RN;Kirby JT;Beach ML;Biedenbach DJ;Pfaller MA;; |
Journal | Diagnostic microbiology and infectious disease |
Year | 2002 |
DOI | DOI not found |
URL | |
Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
population surveillance
pseudomonas aeruginosa / drug effects*
anti-bacterial agents / pharmacology
pseudomonas infections / microbiology
pseudomonas aeruginosa / isolation & purification
fluoroquinolones
global health
anti-infective agents / pharmacology
pmid:12106958
doi:10.1016/s0732-8893(02)00390-5
ronald n jones
jeffrey t kirby
michael a pfaller
aminoglycosides
cefepime
ceftazidime / pharmacology
cephalosporins / pharmacology
beta-lactams / pharmacology*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.